|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
14.740 +0.200 (+1.376%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.33
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 104.00 RMB (cts) | |
| Net Profit | 2,769.89 RMB (MIL) | DPS | 32.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 3,201.50 | 120.00 | 40.00 | -- | 3,616.00 | 2,973.00 |
| 2026 | 3,696.50 | 138.50 | 40.00 | -- | 4,174.00 | 3,233.00 |
| 2027 | 4,026.50 | 150.50 | 41.70 | -- | 4,341.00 | 3,712.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 3,139.00 | 118.00 | -- | CITIC SEC | Buy | 20.00 | 08/04/2025 | |
| 2025 | 3,484.00 | 130.00 | 42.00 | CICC | OutPerform | 18.60 | 31/03/2025 | |
| 2025 | 3,616.00 | 135.40 | 40.60 | CITIGROUP | Buy | 18.00 | 27/03/2025 | |
| 2025 | 3,264.00 | 122.00 | 40.00 | CLSA | OutPerform | 15.80 | 23/01/2025 | |
| 2025 | 3,094.00 | 116.00 | 39.06 | MORGAN STANLEY | Equal-weight | 14.20 | 26/03/2025 | |
| 2025 | 2,973.00 | 116.00 | 33.00 | HSBC | Hold | 13.00 | 27/01/2025 | |
| 2026 | 3,636.00 | 136.00 | -- | CITIC SEC | -- | -- | 08/04/2025 | |
| 2026 | 4,174.00 | 156.00 | 52.00 | CICC | -- | -- | 31/03/2025 | |
| 2026 | 3,233.00 | 121.00 | 36.30 | CITIGROUP | -- | -- | 27/03/2025 | |
| 2026 | 3,757.00 | 141.00 | 40.00 | CLSA | -- | -- | 23/01/2025 | |
| 2026 | 3,846.00 | 144.00 | 48.83 | MORGAN STANLEY | -- | -- | 26/03/2025 | |
| 2026 | 3,236.00 | 126.00 | 36.00 | HSBC | -- | -- | 27/01/2025 | |
| 2027 | 4,341.00 | 162.00 | -- | CITIC SEC | -- | -- | 08/04/2025 | |
| 2027 | 3,712.00 | 139.00 | 41.70 | CITIGROUP | -- | -- | 27/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 23/04/2025 09:38 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,769,886 |
| %Change | 15.479% |
| EPS / (LPS) | RMB 1.040 |
| NBV Per Share (¥) | RMB 17.766 |